Bortecad Bortezomib 2 mg Injection
1200 INR/Piece
Product Details:
- Dosage Form Injection
- Indication Multiple Myeloma, Mantle Cell Lymphoma
- Salt Composition Bortezomib 2 mg
- Enzyme Types Other
- Feature Other
- Ingredients Other
- Application Cancer Treatment
- Click to View more
X
Bortecad Bortezomib 2 mg Injection Price And Quantity
- 1200 INR/Piece
- 1 Piece
- Vial
- Bortecad
- Intravenous or Subcutaneous
- Prescription Only
- Proteasome Inhibitor for Oncology Use
- 2 mg/vial
- 1 vial per box
Bortecad Bortezomib 2 mg Injection Product Specifications
- Other
- Bortezomib 2 mg
- Slight Smell
- Multiple Myeloma, Mantle Cell Lymphoma
- 24 months
- Dry Place
- Other
- White Lyophilized Powder
- Injection
- Cancer Treatment
- Other
- Vial
- Bortecad
- Intravenous or Subcutaneous
- Prescription Only
- Proteasome Inhibitor for Oncology Use
- 2 mg/vial
- 1 vial per box
Bortecad Bortezomib 2 mg Injection Trade Information
- Cash Advance (CA)
- 7 Days
Product Description
Technical Specification
- Minimum Order Quantity : 1 Vial
- Shelf life : 1
- Form : Injection
- Packaging Size : vial
- Prescription/Non prescription : Prescription
- Treatment : cancer
- Manufacturer : cadila
- Composition : bortezomib
- Brand : bortecad
Advanced Oncology Care
Bortecad Bortezomib Injection offers a modern approach towards treating multiple myeloma and mantle cell lymphoma. Utilizing Bortezomib's unique proteasome inhibitory action, this injection targets cancer at the cellular level for improved outcomes. Its potent ingredients and sterile formulation contribute to its effective role in cancer therapy, helping medical professionals better manage challenging oncology cases.
Reliable Formulation and Packaging
Bortecad Bortezomib comes as a white lyophilized powder in a 2 mg vial, with each unit individually packed to maintain safety and quality. Designed for intravenous or subcutaneous administration, the product provides flexibility according to patient needs. The 24-month shelf life and dry-storage requirement help retain its efficacy throughout its intended use.
FAQ's of Bortecad Bortezomib 2 mg Injection:
Q: How should Bortecad Bortezomib Injection be administered?
A: Bortecad Bortezomib Injection is given either intravenously or subcutaneously by a qualified healthcare professional. The exact mode and dosage depend on the patient's condition and doctor's instructions.Q: What is Bortecad Bortezomib used for?
A: This injection is primarily used in the treatment of multiple myeloma and mantle cell lymphoma. It works as a proteasome inhibitor, disrupting the growth of cancer cells.Q: When should Bortecad Bortezomib be administered during cancer treatment?
A: Administration timing and regimen are determined by an oncologist based on the patient's treatment cycle and individual response to therapy. It must always be used under medical supervision.Q: Where should I store Bortecad Bortezomib Injection?
A: Keep the vials in a dry place at the recommended temperature. Avoid exposure to moisture and extreme temperatures to preserve the medication's efficacy until its 24-month expiry date.Q: What are the main benefits of using Bortecad Bortezomib Injection?
A: Its primary benefit is targeted inhibition of proteasomes in cancer cells, which restricts tumor growth and aids in managing challenging blood cancers. It offers flexibility in administration and maintains potency with proper storage.Q: Is a prescription required for Bortecad Bortezomib 2 mg Injection?
A: Yes, this medication is available strictly by prescription and should only be administered under the supervision of a qualified healthcare professional.Tell us about your requirement
Price:
Quantity
Select Unit
- 50
- 100
- 200
- 250
- 500
- 1000+
Additional detail
Mobile number
Email
Other Products in 'Anti Cancer Injection' category
DEV MEDICAL
All Rights Reserved.(Terms of Use)
Developed and Managed by Infocom Network Private Limited.
Developed and Managed by Infocom Network Private Limited.
